Cargando…
An ELISA-based high throughput protein truncation test for inherited breast cancer
INTRODUCTION: Breast cancer is the most diagnosed and second leading cause of cancer deaths in the U.S. female population. An estimated 5 to 10 percent of all breast cancers are inherited, caused by mutations in the breast cancer susceptibility genes (BRCA1/2). As many as 90% of all mutations are no...
Autores principales: | Lim, Mark J, Foster, Gabriel J, Gite, Sadanand, Ostendorff, Heather P, Narod, Steven, Rothschild, Kenneth J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096971/ https://www.ncbi.nlm.nih.gov/pubmed/20920338 http://dx.doi.org/10.1186/bcr2722 |
Ejemplares similares
-
Photocleavage-based affinity purification of biomarkers from serum: Application to multiplex allergy testing
por: Wan, Zhi, et al.
Publicado: (2018) -
Excess of rare, inherited truncating mutations in autism
por: Krumm, Niklas, et al.
Publicado: (2015) -
Truncating TINF2 p.Tyr312Ter variant and inherited breast cancer susceptibility
por: Koivuluoma, Susanna, et al.
Publicado: (2022) -
Truncated MTA-1: A Pitfall in ELISA-Based Immunoassay of HTLV-1 Infection
por: Abbaszadegan, Mohammad Reza, et al.
Publicado: (2008) -
Optimization and Validation of Indirect ELISA Using Truncated TssB Protein for the Serodiagnosis of Glanders amongst Equines
por: Singha, Harisankar, et al.
Publicado: (2014)